Gene & Cell Therapies: The Dawn of a New Era?

EUCOPE, together with SME Connect and SME Europe hosted an event on the opportunities and challenges of gene and cell therapies in Europe: Read the report for insights and thought-provoking conclusions.

Upcoming Meetings

Regulatory / Medical Devices Meeting, Brussels, 2 May

OMP Meeting, Brussels, 15 May

Market Access / Pricing & Reimbursement Meeting, Brussels, 4 June

Calendar

EUCOPE Membership

The content of the member area is exclusively available for members of EUCOPE.

To learn more about the advantages of the EUCOPE membership please contact us.

Contact us or Login

EUCOPE – the European Confederation of Pharmaceutical Entrepreneurs

EUCOPE is Europe’s trade body for small to medium-sized innovative companies working in the field of pharmaceuticals, biotechnologies and medical technologies.

Based in Brussels, Belgium, EUCOPE gives voice to more than 120 research-oriented innovative companies and associations active in research, development of pharmaceuticals, biotechnologies and medical devices. Many of our members are developing therapeutic solutions for persons living with a rare disease, who had little to no treatment available just a few years ago.

As an industry stakeholder recognised by the European Institutions (EMA, European Commission, European Parliament and Council) and by national authorities, EUCOPE is following important EU and national legislative dossiers in market access, rare diseases, pharmacovigilance, and medical devices, with a speficic focus on the incentives framework.

Together with our members, we work to ensure an effective framework is in place to allow small to medium-sized pharmaceutical companies to continue to provide innovative solutions for patients in Europe.